“As administrations change, federal agencies’ leadership often changes to align with the incoming president’s priorities,” ...
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Otsuka has dumped a clutch of clinical cancer candidates on Valentine's day. | Otsuka has broken up with a clutch of clinical ...
Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...
After its depression candidate failed a phase 3 trial and disappointed analysts, Neumora is shaking up its leadership team.
Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned. ...
Volta Medical put forward new data showing its artificial-intelligence-guided ablation procedures were able to improve ...
Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...
Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...
Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
After offering a deep dive last year into the recipe behind its lead lung fibrosis candidate, Insilico Medicine is now giving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results